Broadwood Partners seeks to remove three STAAR Surgical directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors
December 2, 2025 4:15 PM ESTPursuing Board Changes to Restore Investor Confidence and Ensure Integrity of Ongoing Sale Process
Broadwood Seeks to Remove the Directors Most Responsible for the Flawed Sale Process: Board Chair Elizabeth Yeu, CEO Stephen Farrell, and Compensation Committee Chair Arthur Butcher
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (collectively, Broadwood) today announced that it is well along in the multi-step and time-consuming process that is required to call a Special Meeting of Shareholders (the Special Meeting) at STAAR Surgical Company (STAAR or the Company) (NASDAQ:... More
